GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (STU:NR1A) » Definitions » Cyclically Adjusted Price-to-FCF

National Research (STU:NR1A) Cyclically Adjusted Price-to-FCF : 20.66 (As of Jun. 01, 2024)


View and export this data going back to 2017. Start your Free Trial

What is National Research Cyclically Adjusted Price-to-FCF?

As of today (2024-06-01), National Research's current share price is €25.20. National Research's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.22. National Research's Cyclically Adjusted Price-to-FCF for today is 20.66.

The historical rank and industry rank for National Research's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

STU:NR1A' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.51   Med: 25.1   Max: 47.36
Current: 20.7

During the past years, National Research's highest Cyclically Adjusted Price-to-FCF was 47.36. The lowest was 7.51. And the median was 25.10.

STU:NR1A's Cyclically Adjusted Price-to-FCF is ranked better than
53.71% of 175 companies
in the Healthcare Providers & Services industry
Industry Median: 23.69 vs STU:NR1A: 20.70

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

National Research's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.303. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.22 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


National Research Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for National Research's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Cyclically Adjusted Price-to-FCF Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.31 30.84 32.00 28.74 29.82

National Research Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.22 32.72 33.70 29.82 29.14

Competitive Comparison of National Research's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, National Research's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where National Research's Cyclically Adjusted Price-to-FCF falls into.



National Research Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

National Research's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=25.20/1.22
=20.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Research's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, National Research's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.303/131.7762*131.7762
=0.303

Current CPI (Mar. 2024) = 131.7762.

National Research Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.161 100.560 0.211
201409 0.271 100.428 0.356
201412 0.171 99.070 0.227
201503 0.031 99.621 0.041
201506 0.246 100.684 0.322
201509 0.181 100.392 0.238
201512 0.240 99.792 0.317
201603 0.120 100.470 0.157
201606 0.208 101.688 0.270
201609 0.215 101.861 0.278
201612 0.304 101.863 0.393
201703 0.253 102.862 0.324
201706 0.054 103.349 0.069
201709 0.319 104.136 0.404
201712 0.178 104.011 0.226
201803 0.221 105.290 0.277
201806 0.261 106.317 0.324
201809 0.183 106.507 0.226
201812 0.386 105.998 0.480
201903 0.214 107.251 0.263
201906 0.265 108.070 0.323
201909 0.413 108.329 0.502
201912 0.375 108.420 0.456
202003 0.174 108.902 0.211
202006 0.261 108.767 0.316
202009 0.314 109.815 0.377
202012 0.469 109.897 0.562
202103 0.431 111.754 0.508
202106 0.310 114.631 0.356
202109 0.256 115.734 0.291
202112 0.358 117.630 0.401
202203 0.206 121.301 0.224
202206 0.318 125.017 0.335
202209 0.247 125.227 0.260
202212 0.234 125.222 0.246
202303 0.172 127.348 0.178
202306 0.168 128.729 0.172
202309 0.203 129.860 0.206
202312 0.297 129.419 0.302
202403 0.303 131.776 0.303

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


National Research  (STU:NR1A) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


National Research Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of National Research's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (STU:NR1A) Business Description

Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.

National Research (STU:NR1A) Headlines

No Headlines